SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Ginor Ron

(Last) (First) (Middle)
C/O STEADYMED THERAPEUTICS, INC.
2603 CAMINO RAMON, SUITE 350

(Street)
SAN RAMON CA 94583

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
SteadyMed Ltd. [ STDY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/25/2015
4. If Amendment, Date of Original Filed (Month/Day/Year)
03/25/2015
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 03/25/2015 C 1,034,102 A (1) 1,034,102 I See Footnote(2)
Ordinary Shares 03/25/2015 A 41,000 A $8.5 1,075,102 I See Footnote(2)
Ordinary Shares 03/25/2015 C 16,298 A (1) 16,298 I See Footnote(3)
Ordinary Shares 03/25/2015 C 94,643 A (1) 94,643 I See Footnote(4)
Ordinary Shares 03/25/2015 J(5) 10,663 A $0.01 105,306 I See Footnote(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Series A-2 Convertible Preferred Shares (1) 03/25/2015 C 198,393 (1) (6) Ordinary Shares 198,393 $6.62 0 I See Footnote(2)
Series B Convertible Preferred Shares (1) 03/25/2015 C 286,944 (1) (6) Ordinary Shares 286,944 $4.07 0 I See Footnote(2)
Series D Convertible Preferred Shares (1) 03/25/2015 C 151,791 (1) (6) Ordinary Shares 151,791 $6.14 0 I See Footnote(2)
Series E Convertible Preferred Shares (1) 03/25/2015 C 396,974 (1) (6) Ordinary Shares 396,974 $8.49 0 I See Footnote(2)
Series D Convertible Preferred Shares (1) 03/25/2015 C 16,298 (1) (6) Ordinary Shares 16,298 $6.14 0 I See Footnote(3)
Series E Convertible Preferred Shares (1) 03/25/2015 C 94,643 (1) (6) Ordinary Shares 94,643 $8.49 0 I See Footnote(4)
Warrant to Purchase Series E Preferred Shares $0.01 03/25/2015 J(5) 10,664 (5) 02/17/2021 Ordinary Shares 10,664 $0 0 I See Footnote(4)
Explanation of Responses:
1. Such preferred shares converted into that number of Issuer's ordinary shares disclosed above at the closing of a Qualified IPO (as defined in the Issuer's Ninth Amended and Restated Articles of Association dated March 1, 2015).
2. By Samson Venture Partners I, LLC. Samson Venture Partners, LLC is the Manager and the Reporting Person is a Co-Manager of Samson Venture Partners, LLC.
3. By Randsburg Capital, LLC. Reporting Person is a Co-Manager of Randsburg Capital, LLC.
4. By Iron Capital I, LLC. Iron Capital, LLC is the Manager and the Reporting Person is the Sole Manager of Iron Capital, LLC.
5. The Reporting Person exercised this warrant on a cashless basis, resulting in the Issuer withholding 1 share subject to the warrant to pay for the exercise price. Upon exercise the Reporting Person acquired 10,663 shares.
6. The shares do not have an expiration date.
Remarks:
This Form 4/A amends the Form 4 filed by the Reporting Person on March 25, 2015 to include the securities held by and transactions with respect to Iron Capital I, LLC and Randsburg Capital, LLC.
/s/Ron Ginor 07/20/2015
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.